Evidence map›Paper›PMID 40104669›Full record

ReviewMultiple sclerosis journal - experimental, translational and clinical

Characterizing the diversity of the multiple sclerosis population in Canada: A scoping review.

Ruth Ann Marrie, Afolasade Fakolade, Janice Linton, Colleen J Maxwell, Dalia Rotstein, Brayden Schindell, Helen Tremlett, Ann Yeh, Marcia Finlayson

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruth Ann MarrieDepartment of Medicine, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.ORCID https://orcid.org/0000-0002-1855-5595
Afolasade FakoladeSchool of Rehabilitation Therapy, Queen's University, Kingston, ON, Canada.ORCID https://orcid.org/0000-0003-3405-5782
Janice LintonNeil John Maclean Health Sciences Library, University of Manitoba, Winnipeg, MB, Canada.ORCID https://orcid.org/0000-0002-3210-9022
Colleen J MaxwellSchools of Pharmacy and Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.ORCID https://orcid.org/0000-0002-7988-2899
Dalia RotsteinDepartment of Medicine, University of Toronto, Toronto, ON, Canada; St. Michael's Hospital, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-7280-3684
Brayden SchindellDepartment of Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.ORCID https://orcid.org/0009-0005-8000-1998
Helen TremlettDepartment of Medicine, University of British Columbia and The Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada.ORCID https://orcid.org/0000-0001-5804-2535
Ann YehDepartment of Paediatrics, Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-5393-7417
Marcia FinlaysonSchool of Rehabilitation Therapy, Queen's University, Kingston, ON, Canada.ORCID https://orcid.org/0000-0002-1774-4810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This scoping review aimed to identify existing information and gaps in knowledge regarding the diversity characteristics of the multiple sclerosis (MS) population in Canada. Methods: We searched MEDLINE, EMBASE, Cumulated Index in Nursing and Allied Health Literature (CINAHL), SCOPUS and ProQuest's global dataset of theses and dissertations from 2010 to January 12, 2024. Data sources were case reports/series, cohort studies, case-control studies, analytical cross-sectional studies, randomized clinical trials, qualitative, mixed methods, participatory studies and systematic reviews conducted in Canada, published in English or French, that included participants with clinically isolated syndrome or MS. Sample characteristics were extracted applying Cochrane's PROGRESS-Plus framework. Results: We included 259 studies, most often studying disease-modifying therapy (24.3%) and access to care (20.9%). Among primary data collection studies 40% used one recruitment strategy, usually MS Clinics and MS Canada. Age (92.7%) and sex (86.9%) were reported most often, ≤10% of studies reported race or ethnicity; religion, sexual orientation and language were not reported. Conclusions: We lack an understanding of characteristics of people living with MS in Canada relevant to health equity. Existing research has been insufficiently inclusive. Better reporting of diversity characteristics is needed, along with specific efforts to recruit and retain more diverse samples.

Indexed as

Canadadiversityepidemiologymultiple sclerosisScoping reviewsocial determinants of health

Identifiers

PMID40104669
PMCPMC11915319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.